Molecular Formula | C17H16N4O4 |
Molar Mass | 340.33 |
Density | 1.44±0.1 g/cm3(Predicted) |
pKa | 0.58±0.53(Predicted) |
Storage Condition | -20℃ |
Use | Enarodustat is an effective, orally available factor prolyl hydroxylase inhibitor, EC50 of 0.22 μM. Enarodustat has the potential to be used in the study of renal anemia. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.938 ml | 14.692 ml | 29.383 ml |
5 mM | 0.588 ml | 2.938 ml | 5.877 ml |
10 mM | 0.294 ml | 1.469 ml | 2.938 ml |
5 mM | 0.059 ml | 0.294 ml | 0.588 ml |
biological activity | Enarodustat (JTZ-951) is a potent, the IC50 value for PHD2 was 0.22 μm and the EC50 value for EPO release from Hep3B cells was 5.7 μm. Enarodustat has the potential to treat renal anemia. |
Target | Value |
PHD2 (Cell-free assay) | 0.22 μM |
EPO release from Hep3B cells (Cell-based assay) | 5.7 μM(EC50) |